company background image
VINC logo

Vincerx Pharma NasdaqCM:VINC Stock Report

Last Price

US$5.06

Market Cap

US$129.6m

7D

-7.2%

1Y

419.7%

Updated

28 Mar, 2024

Data

Company Financials +

Vincerx Pharma, Inc.

NasdaqCM:VINC Stock Report

Market Cap: US$129.6m

VINC Stock Overview

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.

VINC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Vincerx Pharma, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vincerx Pharma
Historical stock prices
Current Share PriceUS$5.06
52 Week HighUS$9.37
52 Week LowUS$0.61
Beta0.76
1 Month Change24.94%
3 Month Change328.81%
1 Year Change419.72%
3 Year Change-73.69%
5 Year Changen/a
Change since IPO-45.88%

Recent News & Updates

Recent updates

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Jul 18
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Mar 30
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Sep 22
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Jun 24
Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Vincerx Pharma doses first patient in early-stage VIP152 cancer study

Jun 03

Shareholder Returns

VINCUS BiotechsUS Market
7D-7.2%0.9%0.4%
1Y419.7%10.3%28.8%

Return vs Industry: VINC exceeded the US Biotechs industry which returned 10.3% over the past year.

Return vs Market: VINC exceeded the US Market which returned 28.8% over the past year.

Price Volatility

Is VINC's price volatile compared to industry and market?
VINC volatility
VINC Average Weekly Movement29.8%
Biotechs Industry Average Movement11.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: VINC's share price has been volatile over the past 3 months.

Volatility Over Time: VINC's weekly volatility has increased from 19% to 30% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201941Ahmed Hamdyhttps://vincerx.com

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company’s preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies.

Vincerx Pharma, Inc. Fundamentals Summary

How do Vincerx Pharma's earnings and revenue compare to its market cap?
VINC fundamental statistics
Market capUS$129.57m
Earnings (TTM)-US$48.85m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VINC income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$48.85m
Earnings-US$48.85m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.28
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did VINC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.